Brooks unveils advanced temperature monitoring system at Montreal biobank

Montreal biobank temperature monitoring system

INDIANAPOLIS, Ind. and MONTREAL, Qué – January 2020 – Brooks Life Sciences is taking biobank monitoring to the next level with the upgrade of a state-of-the-art temperature tracking system at the Montreal, Quebec site.

Brooks has partnered with a world leader in connected solutions that support compliance, quality management, and traceability for life sciences, pharma, and more.

Vice President of Services and Informatics for Brooks Life Sciences, Martin Long, says the installation at Montreal is part of ongoing continuous improvement efforts at all Brooks Life Sciences biobanking sites.

“This new temperature monitoring solution will allow Brooks to maintain temperature when moving freezers within the facility, extend temperature monitoring to include sample management carts, and improve redundancy of alarm systems,” Long shares.

The next two sites scheduled for temperature monitoring upgrades are El Segundo and Fresno, CA. All sites will transition to the new system by end of Q1 2020.

According to Geraint Phillips, Senior Director of Global Operations for Brooks Life Sciences, “The installation at the Montreal biobank marks a significant step toward the company’s plan for continuous global monitoring and remote alarm management.”

Additional data sources to be integrated in the future include asset tracking, validation, calibration, and utilities monitoring.

About Brooks Life Sciences
Brooks Life Sciences, a division of Brooks Automation, provides the life sciences industry with the most comprehensive portfolio of sample management solutions, enabling researchers worldwide to accelerate innovation and improve patient health. The company provides automated storage, cryopreservation, informatics, sample and GMO storage, and gene sequencing and synthesis through their company, GENEWIZ. Brooks also offers lab services, transportation, consumables, and instruments. Technologies and services span the entire cold chain supporting research, GMP, pre/clinical, cell therapy, and biologics. The top 20 biopharmaceutical providers and other leading companies rely on Brooks Life Sciences to advance research.